Algert Global LLC Novo Cure LTD Transaction History

Algert Global LLC

$4.77 Billion
Q2 2025

A detailed history of Algert Global LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Algert Global LLC holds 144,623 shares of NVCR stock, worth $2.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

144,623

Previous 97,751 47.95%

Holding current value

$2.12 Million

Previous $1.74 Million 47.76%

% of portfolio

0.05%

Previous 0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$15.37 - $19.4 $720,422 - $909,316	46,872 Added 47.95%	144,623 $2.57 Million
Q1 2025 May 13, 2025	BUY	$17.82 - $30.19 $507,691 - $860,113	28,490 Added 41.13%	97,751 $1.74 Million
Q4 2024 Feb 14, 2025	BUY	$14.54 - $33.41 $1.01 Million - $2.31 Million	69,261 New	69,261 $2.06 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $203,511 - $413,732	-17,203 Reduced 55.49%	13,800 $236,000
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $385,057 - $536,041	31,003 New	31,003 $485,000
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $85,477 - $114,054	-1,336 Reduced 19.92%	5,371 $394,000
Q3 2022 Nov 15, 2022	BUY	$67.99 - $89.57 $456,008 - $600,745	6,707 New	6,707 $510,000
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $973,146 - $1.49 Million	-7,841 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $1.24 Million - $1.93 Million	-11,099 Reduced 58.6%	7,841 $1.36 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $1.1 Million - $2.11 Million	18,940 New	18,940 $2.11 Million

Others Institutions Holding NVCR

# of Institutions

285

Shares Held

77.5M

Call Options Held

943K

Put Options Held

155K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.54B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Novo Cure LTD Transaction History